U.S. markets closed

Inari Medical, Inc. (NARI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
96.23+0.31 (+0.32%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close95.92
Open97.87
Bid94.17 x 1100
Ask98.76 x 800
Day's Range95.87 - 100.66
52 Week Range39.55 - 127.42
Volume397,560
Avg. Volume584,445
Market Cap4.771B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateMay 11, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est128.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
2% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Hot Stocks To Watch Or Buy Now: Mutual Funds Like These 5 Top Stocks
      Investor's Business Daily

      Hot Stocks To Watch Or Buy Now: Mutual Funds Like These 5 Top Stocks

      A top IPO and big dividend payer are among five market hot stocks big mutual funds are starting positions or increasing their stakes in.

    • Inari Medical to Present at the 2021 Bank of America Healthcare Conference
      GlobeNewswire

      Inari Medical to Present at the 2021 Bank of America Healthcare Conference

      IRVINE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will present at the 2021 Bank of America Healthcare Conference on Thursday, May 13, 2021 at 8:45 a.m. Eastern Time. About Inari Medical, Inc.Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium. Investor Contact:Westwicke PartnersCaroline CornerPhone +1-415-202-5678 caroline.corner@westwicke.com

    • Top Small-Cap Stocks for May 2021
      Investopedia

      Top Small-Cap Stocks for May 2021

      Small-cap stocks are public companies that have market capitalizations ranging from $300 million to $2 billion. Since the share prices of these companies can be very volatile, some companies in the small-cap universe or in small-cap indexes can have market caps significantly higher than this range at any particular time. Small-cap stocks, as represented by the Russell 2000 Index, have significantly outperformed the broader market, providing investors with a total return of 88.5% compared to the Russell 1000's total return of 54.4% over the past 12 months.